Successful treatment of myasthenia gravis with tacrolimus

Muscle and Nerve

Volumn 25, Issue 1, 2002, Pages 111-114

  Evoli, Amelia ^a   Schino, Chiara Di ^a   Marsili, Francesca ^a   Punzi, Chiara ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Cyclosporine; Diabetes mellitus; HCV infection; Myasthenia gravis; Tacrolimus

Indexed keywords

ALPHA2B INTERFERON; AZATHIOPRINE; CYCLOSPORIN A; EDROPHONIUM; METFORMIN; RECOMBINANT ALPHA2B INTERFERON; STEROID; TACROLIMUS;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; DRUG SAFETY; HEPATITIS C; HUMAN; LIVER TOXICITY; MALE; MYASTHENIA GRAVIS; NEPHROTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TREATMENT INDICATION;

ANTIVIRAL AGENTS; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-ALPHA; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; TACROLIMUS;

EID: 0036136116     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10018     Document Type: Article

References (23)

1. Myasthenia gravis during interferon alfa therapy
2. Mycophenolate mofetil in myasthenia gravis: An open-label pilot study
3. Genetics of drug response to immunosuppressive treatment and prospects for personalized therapy
4. Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future
5. Myasthenia gravis
6. Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of three cases
7. Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha
8. Randomized trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection
9. Systemic lupus erythematosus after alpha-interferon therapy for chronic hepatitis C: A case report and review of the literature
10. Anti-GABAergic neurons autoantibodies in a patient with stiff-man syndrome and ataxia
11. FK-506-induced autoimmune diabetes
12. A treatment algorithm for autoimmune myasthenia in adults
13. FK-506 (tacrolimus) therapy for an unusual SLE-like disease
14. Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis
15. Conversion of renal transplant recipients from cyclosporine to low-dose tacrolimus for refractory rejection
16. Overview of new immunosuppressive therapy
17. A comparison of tacrolimus (FK506) and cyclosporine for immunosoppression after cadaveric renal transplantation
18. A novel management strategy of steroid-free immunosuppression after liver transplantation: Efficacy and safety of tacrolimus and mycophenolate mofetil
19. Myasthenia gravis. Recommendations for clinical research standards
20. Exacerbation of myasthenia gravis during interferon-alpha treatment
21. Tacrolimus: A potential new treatment for autoimmune chronic active hepatitis: Results of an open-label preliminary trial
22. Detection of islet cell specificity of monoclonal islet cell surface antibodies by means of double-staining immunoflorescence
23. FK506 prevents induction of rat experimental autoimmune myasthenia gravis